R Squared’s Treace Medical Concepts TMCI Stock Holding History

R Squared’s Portfolio TMCI Stock Details TMCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-3,170	Closed	-$23.6K	–	1406
2024 Q4	$23.6K	Buy	+3,170	New	+$21.2K	0.02%	803

Other funds holding TMCI

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

R Squared's TMCI Position: Q1 2025 in Review

R Squared sold out of Treace Medical Concepts (TMCI) in Q1 2025, closing a stake of 3,170 shares — an estimated $23.6K sold.

R Squared first reported a position in TMCI in Q4 2024 and held it in 1 quarter. The position peaked at $23.6K in Q4 2024. 138 funds tracked by Wall St. Rank hold TMCI as of Q1 2025.

R Squared reported no remaining Treace Medical Concepts position as of Q1 2025 after selling out during the quarter.
R Squared sold 3,170 Treace Medical Concepts shares in Q1 2025, an estimated $23.6K.
R Squared first reported a position in Treace Medical Concepts in Q4 2024 and held it in 1 quarter.
R Squared's Treace Medical Concepts position peaked at $23.6K in Q4 2024.
138 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q1 2025.

Based on R Squared's 13F filing for Q1 2025, filed 9 May 2025.